We have fabricated Cu2ZnSnSe4-CdS-ZnO solar cells with a total area efficiency of 9.7%. The absorber layer was fabricated by selenization of sputtered Cu10Sn90, Zn, and Cu multilayers. A large ideality factor of the order of 3 is observed in both illuminated and dark IV-curves, which seems to point in the direction of complex recombination mechanisms such as recombination through fluctuating potentials in the conduction and valence bands of the solar cell structure. A potential barrier of about 135 meV in the device seems to be responsible for an exponential increase of the series resistance at low temperatures, but at room temperature, the effect of this barrier remains relatively small. The free carrier density in the absorber is of the order of 1015 cm−3 and does not vary much as the temperature is decreased.
Articles you may be interested inBiaxially strained extremely-thin body In0.53Ga0.47As-on-insulator metal-oxide-semiconductor field-effect transistors on Si substrate and physical understanding on their electron mobility
The authors show the implications that the free carrier trapping lifetime has on the capacitance-voltage (CV) characterization method applied to metal-oxide-semiconductor (MOS) structures. It is shown that, whereas the CV characterization method for deducing interface state densities works well for Si, the generally used frequency range of 100Hz–1MHz is much less adapted to GaAs MOS structures. Only interface trapping states in very small portions of the GaAs bandgap are measured with this frequency range, and mainly the very important midgap region is not properly probed. Performing an additional measurement at 150°C on GaAs MOS structures eliminates this problem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.